Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors

Protein kinases have emerged as crucial targets for cancer therapy over the last decades. Since 2001, 40 and 39 kinase inhibitors have been approved by FDA and EMA, respectively, and the majority are antineoplastic drugs. Morevoer, many candidates are currently in clinical trials. We previously repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Francini, Cinzia Maria, Musumeci, Francesca, Fallacara, Anna Lucia, Botta, Lorenzo, Molinari, Alessio, Artusi, Roberto, Mennuni, Laura, Angelucci, Adriano, Schenone, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225123/
https://www.ncbi.nlm.nih.gov/pubmed/30227617
http://dx.doi.org/10.3390/molecules23092369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225123/
https://www.ncbi.nlm.nih.gov/pubmed/30227617
http://dx.doi.org/10.3390/molecules23092369

Ejemplares similares